polycythemia
TRANSCRIPT
![Page 1: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/1.jpg)
POLYCYTHEMIAPOLYCYTHEMIA
Aaron Mascarenhas080201022
![Page 2: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/2.jpg)
DefinitionDefinition
“Polycythemia is defined as an increase in the circulating red blood cells above normal.” Erythrocytosis-?
![Page 3: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/3.jpg)
When should I be When should I be worried?worried?
• When the haemoglobin level is at 18.5g/dL in men or 17g/dL in women it MAY be abnormal.
• Hct levels >60% in men and >55% in women is almost INVARIABLY associated with an increased cell mass.
![Page 4: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/4.jpg)
Pathophysiologic ClassificationRELATIVE
Reduced plasma volume (hemoconcentration)
ABSOLUTE
Primary (Erythropoietin normal or low) Polycythemia veraInherited erythropoietin receptor mutations
Secondary (High erythropoietin) Compensatory
Lung diseaseHigh-altitude livingCyanotic heart disease
ParaneoplasticErthropoietin secreting tumors
Haemoglobin mutants with high O2 affinity Inherited defects that stabilize HIF-α
Chuvash Polycythemia (homozygous VHL mutations) Prolyl hydroxylase mutations
![Page 5: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/5.jpg)
• Historic features: – Smoking history,– living at a high altitude, – congenital heard disease, – peptic ulcer disease(?), – sleep apnea, – chronic lung disease, – renal disease.
![Page 6: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/6.jpg)
ALGORITHM
![Page 7: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/7.jpg)
POLYCYTHEMIA VERAPOLYCYTHEMIA VERA
• “A myeloproliferative disease arising from a clonal HSC and resulting in uncontrolled division of RBC’s.”
• Granulocytes and platelets ↑sed
![Page 8: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/8.jpg)
Clinical FeaturesClinical Features• Most symptoms are related to an increased red
cell mass and elevated haematocrit• Hyperviscocity hence there is sluggish blood flow
which mainly affects the _______ system?• Organomegaly.• Increased risk of bleeding and thrombotic
disorders.– MI, DVT, Stroke, BCS, Bowel infarct– Epistaxis, Bleeding gums. Life threatening(5-10%)
• Plethoric and cyanotic.• Intense pruritis and Peptic Ulceration(?)• Symptomatic gout(5-10%)?
![Page 9: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/9.jpg)
• Bone Marrow:– Hypercellular.– ↑sed red cell progenitors(Mild), also granulocyte
precursors and megakaryocytes. – Extensive marrow fibrosis(Later stages) Displacement
of HC’s Extramedullary Haematopoiesis.• Peripheral Smear:– Hb: 14-28 g/dL; Increase in absolute red cell mas Cr
labelling method– Hct: >60%– Iron deficiency?!– Microcytic erthrocytosis? – TLC: 12,000 – 50,000 cells/. ↑sed Basophils(?)– Platelets: >5,00,000/mm3 (Giant forms, qualitatively
poor)
![Page 10: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/10.jpg)
MOLECULAR MOLECULAR PATHOGENESISPATHOGENESIS
1. JAK 2: ?(97%)2. Important kinase for EPO and Thrombopoietin3. Obligate chaperone for the EPO and TPO receptor4. After binding autophosphorylation, receptor
phosphorylation and phosphorylation of proteins involved in cell differentiation, proliferation and resistance to apoptosis.
5. What if there was no JAK2?6. Constitutive activation?7. AML clones don’t have JAK2 mutations?
![Page 11: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/11.jpg)
• Without treatment: Death within months of diagnosis from bleeding or thrombosis.
• Treatment: – Periodic Phlebotomies – Anagralide(Hydroxyurea?)– INF-α
![Page 12: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/12.jpg)
Gaisbock syndrome (Spurious polycythemia or stress polycythemia):1.Seen in middle aged persons, overweight, hypertensive chronic smokers 2.Due to a combination of plasma volume depletion and increased red cell production.3.Nicotine?4.Carbon Monoxide?
![Page 13: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/13.jpg)
![Page 14: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/14.jpg)
![Page 15: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/15.jpg)
![Page 16: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/16.jpg)
![Page 18: Polycythemia](https://reader035.vdocuments.us/reader035/viewer/2022062220/556af0dad8b42a86218b5390/html5/thumbnails/18.jpg)